Adverse effects of antiepileptic drugs: a brief overview of important issues

References

• Cramer JA, Fisher R, Ben-Menachem E, French J, Mattson RH. New antiepileptic drugs: comparison of key clinical trials. Epilepsia40, 590–600 (1999).
   PubMed Web of Science ®Google Scholar
• Cramer JA, Ben Menachem E, French J. Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation. Epilepsy Res.47, 17–25 (2001).
   PubMedGoogle Scholar
• Hirsch LJ, Weintraub D, Du Y et al. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy. Neurology63(6), 1022–1026 (2004).
   PubMed Web of Science ®Google Scholar
• Mattson RH. Medical management of epilepsy in adults. Neurology51, S15–S20 (1998).
   Google Scholar
• Mattson RH, Cramer JA, Collins JF et al. Early tolerance to anti-epileptic drug side effects: a controlled trial of 247 patients. In: Tolerance to Beneficial and Adverse Effects of Antiepileptic Drugs. Koella WP (Ed.). Raven Press, NY, USA 149–156 (1986).
   Google Scholar
• Mattson RH, Cramer JA, Collins JF et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic clonic seizures. N. Engl. J. Med.313, 145–151 (1985).
   PubMed Web of Science ®Google Scholar
• Cramer JA, Mattson RH, Prevey ML, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. J. Am. Med. Assoc.261, 3273–3277 (1989).
   PubMed Web of Science ®Google Scholar
• Miura H. Zonisamide monotherapy with once-daily dosing in children with cryptogenic localization-related epilepsies: clinical effects and pharmacokinetic studies. Seizure13, S17–S23 (2004).
   PubMed Web of Science ®Google Scholar
• Reunanen M, Dam M, Yuen AW. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res.23, 149–155 (1996).
   PubMed Web of Science ®Google Scholar
• Biton V, Edwards KR, Montouris GD et al. Topiramate titration and tolerability. Ann. Pharmacother.35, 172–179 (2001).
   Google Scholar
• Mattson RH. An overview of the new antiepileptic drugs. Neurologist4, S2–S10 (1998).
   Google Scholar
• Hermann B, Meador BJ, Gaillard WD, Cramer JA. Cognition across the lifespan: antiepileptic drugs, epilepsy, or both? Epilepsy Behav.17, 1–5 (2010).
   PubMedGoogle Scholar
• Vining EPG, Mellits ED, Dorsen MM et al. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics80, 165–174 (1987).
   PubMed Web of Science ®Google Scholar
• Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB. Phenobarbital for febrile seizures – effects on intelligence and on seizure recurrence. N. Engl. J. Med.322, 364–369 (1990).
   PubMed Web of Science ®Google Scholar
• Willmore LJ, Wheless JW, Pellock JM. Adverse effects of antiepileptic drugs. In: Pediatric Epilepsy: Diagnosis and Therapy. Pellock JM, Bourgeois BFD, Dodson WE, Nordli DR Jr, Sankar R (Eds). Demos Medical Publishing, LLC, NY, USA 449–559 (2008).
   Google Scholar
• Meador KJ, Loring DW, Moore EE et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology45, 1494–1499 (1995).
   PubMed Web of Science ®Google Scholar
• Shorvon SD. Safety of topiramate: adverse events and relationships to dosing. Epilepsia37, S18–S22 (1996).
   PubMed Web of Science ®Google Scholar
• Meador KJ. Effects of topiramate on cognition. J. Neurol. Neurosurg. Psychiatry71, 134–135 (2001).
   Google Scholar
• Edwards KR, Kamin M. Efficacy and cognitive side effects of tiagabine and topiramate Neurology48, A39 (1997).
   Google Scholar
• Blumer D, Montouris G, Hermann B. Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. J. Neuropsychol. Clin. Neurosci.7, 445–456 (1995).
   Google Scholar
• Krishnamoorthy ES, Trimble MR, Sander JW, Kanner AM. Forced normalization at the interface between epilepsy and psychiatry. Epilepsy Behav.3, 303–308 (2002).
   Google Scholar
• Cramer JA, De Rue K, Devinsky O, Edrich P, Michael R. Trimble MR. A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder in clinical trials. Epilepsy Behav.4, 124–132 (2003).
   PubMed Web of Science ®Google Scholar
• Hirsch LJ, Arif H, Buchsbaum R et al. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability. Epilepsia48, 1351–1359 (2007).
   PubMedGoogle Scholar
• Kanner AM, Balabanov A. Depression and epilepsy: how closely related are they? Neurology58, 571–585 (2002).
   Google Scholar
• Cramer JA, Brandenburg N, Xiao X. Differentiating anxiety and depression symptoms in patients with partial epilepsy. Epilepsy Behav.6, 563–569 (2005).
   PubMed Web of Science ®Google Scholar
• Schmitz EB, Moriarity J, Costa DC, Ring HA, Ell PJ, Trimble MR. Psychiatric profiles and patterns of cerebral blood flow in focal epilepsy: interactions between depression, obsessionality, and perfusion related to the laterality of the epilepsy. J. Neurol. Neurosurg. Psychiat.62, 458–463 (1997).
   PubMed Web of Science ®Google Scholar
• Parker WA, Shearer CA. Phenytoin hepatotoxicity: a case report and review. Neurology29(2), 175–178 (1979).
   PubMed Web of Science ®Google Scholar
• Besag FM. Behavioural effects of the newer antiepileptic drugs: an update. Expert Opin. Drug Saf.3, 1–8 (2004).
   PubMedGoogle Scholar
• Manjula D, David J, Kulkarni C. Prescribing pattern of anti-seizure medications (ASMs): an evaluation of extent of xanthine co-medication. Pol. J. Pharmacol.54, 285–291 (2002).
   Google Scholar
• Anderson GD. Children versus adults: pharmacokinetic and adverse effect differences. Epilepsia43, 49–53 (2002).
   Google Scholar
• Arif H, Buchsbaum R, Weintraub D et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology68, 1701–1709 (2007).
   PubMed Web of Science ®Google Scholar
• Man CB, Kwan P, Baum L et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia48, 1015–1018 (2007).
   PubMed Web of Science ®Google Scholar
• Cheng SH, Kwan P, Ng NK, Ng MH. New testing approach in HLA genotyping helps overcome barriers in effective clinical practice. Clin. Chem.55(8), 1568–1572 (2009).
   Google Scholar
• Moore TJ, Weiss SR, Kaplan S, Blaisdell CJ. Reported adverse drug events in infants and children under 2 years of age. Pediatrics110, E53–E57 (2002).
   PubMed Web of Science ®Google Scholar
• Mathis LL, Iyasu S. Safety monitoring of drugs granted exclusivity under the Best Pharmaceuticals for Children Act: what the FDA has learned. Clin. Pharmacol. Ther.82, 133–134 (2007).
   Google Scholar
• Johann-Liang R, Wyeth J, Chen M, Cope JU. Pediatric drug surveillance and the Food and Drug Administration’s adverse event reporting system: an overview of reports, 2003–2007. Pharmacoepidemiol. Drug Saf.18, 24–27 (2009).
   PubMed Web of Science ®Google Scholar
• Perucca E, Meador KJ. Adverse effects of antiepileptic drugs. Acta Neurol. Scand.112, 30–35 (2005).
   Web of Science ®Google Scholar
• Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia48, 1223–1244 (2007).
   PubMed Web of Science ®Google Scholar
• McSherry E. Acidosis and growth in nonuremic renal disease. Kidney Int.14, 349–354 (1978).
   Google Scholar
• Camfield P, Camfield C. Monitoring for adverse effects of antiepileptic drugs. Epilepsia47, 31–34 (2006).
   Google Scholar
• Mattson RH, Cramer JA, McCutchen CB; The VA Epilepsy Cooperative Study Group. Barbiturate related connective tissue disorders. Arch. Intern. Med.149, 911–914 (1989).
   Google Scholar
• Mintzer S, Skidmore CT, Abidin CJ et al. Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann. Neurol.65, 448–456 (2009).
   PubMed Web of Science ®Google Scholar
• Ben-Menachem E. Weight issues for people with epilepsy – a review. Epilepsia48, 42–45 (2007).
   PubMedGoogle Scholar
• Sharpe C, Wolfson T, Trauner DA. Weight gain in children treated with valproate. J. Child Neurol.24, 338–341 (2009).
   Google Scholar
• Bootsma HP, Ricker L, Hekster YA et al. The impact of side effects on long-term retention in three new antiepileptic drugs. Seizure18, 327–331 (2009).
   PubMed Web of Science ®Google Scholar